SCYNEXIS INC (37)

Browse by Contract Category

Contracts

Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the Amended and Restated 2015 Inducement Award Plan (Filed With SEC on November 9, 2022)
Amended and Restated 2015 Inducement Award Plan (Filed With SEC on November 9, 2022)
Non-Employee Director Compensation Policy (Filed With SEC on August 15, 2022)
Controlled Equity OfferingSM Sales Agreement, dated May 17, 2021, between SCYNEXIS, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on May 18, 2021)
Employment Agreement, effective May 10, 2021, between SCYNEXIS, Inc. and Christine Coyne (Filed With SEC on May 12, 2022)
Form of Pre-Funded Warrant (Filed With SEC on April 22, 2022)
Form of Warrant (Filed With SEC on April 22, 2022)
Equity Underwriting Agreement, dated April 22, 2022, by and between the Company and Guggenheim Securities, LLC, as representative of the several underwriters named on Schedule I... (Filed With SEC on April 22, 2022)
Description of Common Stock (Filed With SEC on March 29, 2022)
Form of Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on February 8, 2022)
Non-employee Director Compensation Policy (Filed With SEC on August 16, 2021)
Loan and Security Agreement, dated May 13, 2021, among the Company, Hercules Capital Inc., and Silicon Valley Bank (Filed With SEC on August 16, 2021)
Controlled Equity OfferingSM Sales Agreement, dated May 17, 2021, between SCYNEXIS, Inc. and Cantor Fitzgerald & Co (Filed With SEC on May 18, 2021)
Master Services Agreement, effective as of February 4, 2021, by and between SCYNEXIS, Inc. and Amplity, Inc (Filed With SEC on May 17, 2021)
Exclusive License and Collaboration Agreement, made as of February 11, 2021, by and between SCYNEXIS, Inc., Hansoh (Shanghai) Health Technology Co., Ltd. and Jiangsu Hansoh... (Filed With SEC on May 17, 2021)
Fourth Amendment to Termination and License Agreement between SCYNEXIS, Inc. and Merck Sharp & Dohme Corp. dated December 2, 2020 (Filed With SEC on March 29, 2021)
Description of Common Stock (Filed With SEC on March 29, 2021)
Form of Series 1 and Series 2 Warrant (Filed With SEC on December 18, 2020)
Form of Pre-Funded Warrant (Filed With SEC on December 18, 2020)
Equity Underwriting Agreement, dated December 17, 2020, by and between the Company and Guggenheim Securities, LLC, as representative of the several underwriters named on Schedule... (Filed With SEC on December 18, 2020)
SCYNEXIS, Inc. Amended and Restated 2015 Inducement Plan (Filed With SEC on August 10, 2020)
SCYNEXIS, Inc. Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on August 10, 2020)
SCYNEXIS, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 10, 2020)
SCYNEXIS, Inc. Amended and Restated 2009 Stock Option Plan (Filed With SEC on August 10, 2020)
SCYNEXIS, Inc. Amended and Restated Stock Plan (Filed With SEC on August 10, 2020)
Common Stock Purchase Agreement, dated April 10, 2020, between SCYNEXIS, Inc. and Aspire Capital Fund, LLC (Filed With SEC on April 13, 2020)
Registration Rights Agreement, dated April 10, 2020, between SCYNEXIS, Inc. and Aspire Capital Fund, LLC (Filed With SEC on April 13, 2020)
Senior Convertible Note Purchase Agreement, dated as of April 9, 2020, among SCYNEXIS, Inc., as Issuer, Puissance Life Science Opportunities Fund IV, as the Investor, (including... (Filed With SEC on April 9, 2020)
Description of Common Stock (Filed With SEC on March 11, 2020)
Underwriting Agreement, dated December 10, 2019, by and between the Company and H.C. Wainwright & Co., LLC, as representative of the several underwriters named on Schedule I... (Filed With SEC on December 12, 2019)
Form of Warrant (Filed With SEC on December 12, 2019)
SCYNEXIS, Inc. 2015 Inducement Award Plan, Adopted March 26, 2015, Amended June 9, 2015, and form of Stock Option Grant Notice and Stock Option Agreement (Filed With SEC on August 7, 2019)
SCYNEXIS, INC., as Issuer, AND Puissance Life Science Opportunities Fund VI, as the Investor Senior Convertible Note Purchase Agreement Dated as of March 7, 2019 6.0% Convertible... (Filed With SEC on May 8, 2019)
Non-Employee Director Compensation Arrangements (Filed With SEC on March 14, 2019)
Second Amendment to Loan and Security Agreement between SCYNEXIS, Inc. and Solar Capital Ltd. dated March 30, 2018 (Filed With SEC on March 14, 2019)
Senior Convertible Note Purchase Agreement, dated as of March 7, 2019, among SCYNEXIS, Inc., as Issuer, Puissance Capital Management, as the Investor, (including the form of Note... (Filed With SEC on March 8, 2019)
Agreement pursuant to the Technology Business Tax Certificate Transfer Program (Filed With SEC on January 8, 2019)